利拉鲁肽注射剂治疗糖尿病的价值分析

Analysis of the Value of Liraglutide Injection in the Treatment of Diabetes

目的分析利拉鲁肽注射剂治疗糖尿病的价值情况。方法选择2017年6月—2019年6月来该院接受疾病治疗的260例2型糖尿病患者为研究对象,将其分为2组,每组130例。患者在入院之后,接受常规化治疗。所使用药物为二甲双胍片,以此为基础,观察组受试者接受利拉鲁肽治疗疾病,分析结果。结果对照组受试者不良反应发生率为18.5%,观察组为4.6%,两组相比差异有统计学意义(P<0.05)。干预前,2组受试者的BMI、2 hPG、PBG以及FBG指数差异无统计学意义(P>0.05)。干预后,相较于对照组,观察组受试者上述指标改善情况明显更好(P<0.05)。结论对于2型糖尿病患者来讲,以二甲双胍方案为基础,对患者联合应用利拉鲁肽注射液治疗疾病,能够取得满意成效。这种方案有助于控制受试者血糖指标,安全性强、有效性高,可降低不良反应发生概率。

Objective To analyze the value of liraglutide injection in the treatment of diabetes.Methods 260 patients with type 2 diabetes who came to the hospital from June 2017 to June 2019 for disease treatment were selected as the research subjects,and they were divided into 2 groups,130 cases in each group.After admission,patients received routine treatment.The drug used was metformin tablets.On this basis,the subjects in the observation group received liraglutide to treat the disease,and the results were analyzed.Results The incidence of adverse reactions was 18.5%in the control group and 4.6%in the observation group.Compared with the two groups,the difference was statistically significant(P<0.05).Before the intervention,there was no significant difference in BMI,2 hPG,PBG and FBG index between the two groups of subjects(P>0.05).After intervention,compared with the control group,the improvement of the above indicators of the observation group was significantly better(P<0.05).Conclusion For patients with type 2 diabetes,based on the metformin regimen,the combined application of liraglutide injection for patients with disease can achieve satisfactory results.This kind of program is helpful to control the subject's blood glucose index with strong safety and high effectiveness,and can reduce the probability of adverse reactions.